OIE-Office International de Epizootics


International Animal Health Code [INLINE]

TABLE OF CONTENTS

Index
_________________________________________________________________

PART 1
_________________________________________________________________

SECTION 1.1. DEFINITIONS
SECTION 1.2. NOTIFICATIONS AND EPIDEMIOLOGICAL INFORMATION
SECTION 1.3. VETERINARY ETHICS AND CERTIFICATION FOR INTERNATIONAL
TRADE
CHAPTER 1.3.1. General requirements
CHAPTER 1.3.2. Principles of certification
SECTION 1.4. IMPORT RISK ANALYSIS
CHAPTER 1.4.1. General considerations
CHAPTER 1.4.2. Guidelines for risk assessment
CHAPTER 1.4.3. Evaluation of Veterinary Services
CHAPTER 1.4.4. Zoning and regionalisation
CHAPTER 1.4.5. Surveillance and monitoring of animal health
SECTION 1.5. IMPORT/EXPORT PROCEDURES
CHAPTER 1.5.1 Recommendations for transport
CHAPTER 1.5.2. Animal health measures applicable before and at departure
CHAPTER 1.5.3. Animal health measures applicable during transit from the place of departure in the exporting country to the place of arrival in the importing country
CHAPTER 1.5.4. Frontier posts and quarantine stations in the importing country
CHAPTER 1.5.5. Animal health measures on arrival
CHAPTER 1.5.6. International transfer and laboratory containment of animal pathogens
_________________________________________________________________

PART 2
_________________________________________________________________

LIST A DISEASES

CHAPTER 2.1.1. Foot and mouth disease
CHAPTER 2.1.2. Vesicular stomatitis
CHAPTER 2.1.3. Swine vesicular disease
CHAPTER 2.1.4. Rinderpest
CHAPTER 2.1.5. Peste des petits ruminants
CHAPTER 2.1.6. Contagious bovine pleuropneumonia
CHAPTER 2.1.7. Lumpy skin disease
CHAPTER 2.1.8. Rift Valley fever
CHAPTER 2.1.9. Bluetongue
CHAPTER 2.1.10. Sheep pox and goat pox
CHAPTER 2.1.11. African horse sickness
CHAPTER 2.1.12. African swine fever
CHAPTER 2.1.13. Classical swine fever
CHAPTER 2.1.14. Highly pathogenic avian influenza
CHAPTER 2.1.15. Newcastle disease
_________________________________________________________________

PART 3
_________________________________________________________________

LIST B DISEASES

SECTION 3.1. MULTIPLE SPECIES DISEASES
CHAPTER 3.1.1. Anthrax
CHAPTER 3.1.2. Aujeszky's disease
CHAPTER 3.1.3. Echinococcosis/hydatidosis
CHAPTER 3.1.4. Leptospirosis
CHAPTER 3.1.5. Rabies
CHAPTER 3.1.6. Paratuberculosis
CHAPTER 3.1.7. Heartwater
CHAPTER 3.1.8. Screwworm
SECTION 3.2. CATTLE DISEASES
CHAPTER 3.2.1. Bovine brucellosis
CHAPTER 3.2.2. Bovine genital campylobacteriosis
CHAPTER 3.2.3. Bovine tuberculosis
CHAPTER 3.2.4. Enzootic bovine leukosis
CHAPTER 3.2.5. Infectious bovine rhinotracheitis/infectious pustular vulvovaginitis
CHAPTER 3.2.6. Trichomoniasis
CHAPTER 3.2.7. Anaplasmosis
CHAPTER 3.2.8. Babesiosis
CHAPTER 3.2.9. Cysticercosis
CHAPTER 3.2.10. Dermatophilosis
CHAPTER 3.2.11. Theileriosis
CHAPTER 3.2.12. Haemorrhagic septicaemia
CHAPTER 3.2.13. Bovine spongiform encephalopathy
SECTION 3.3. SHEEP AND GOAT DISEASES
CHAPTER 3.3.1. Brucella ovis infection
CHAPTER 3.3.2. Caprine and ovine brucellosis
CHAPTER 3.3.3. Contagious agalactia
CHAPTER 3.3.4. Caprine arthritis/encephalitis
CHAPTER 3.3.5. Maedi-visna
CHAPTER 3.3.6. Contagious caprine pleuropneumonia
CHAPTER 3.3.7. Enzootic abortion of ewes
SECTION 3.4. EQUINE DISEASES
CHAPTER 3.4.1. Contagious equine metritis
CHAPTER 3.4.2. Dourine
CHAPTER 3.4.3. Equine encephalomyelitis
CHAPTER 3.4.4. Equine infectious anaemia
CHAPTER 3.4.5. Equine influenza
CHAPTER 3.4.6. Equine piroplasmosis
CHAPTER 3.4.7. Equine viral rhinopneumonitis
CHAPTER 3.4.8. Glanders
CHAPTER 3.4.9. Horse pox
CHAPTER 3.4.10. Equine viral arteritis
CHAPTER 3.4.11. Mange
CHAPTER 3.4.12. Venezuelan equine encephalomyelitis
CHAPTER 3.4.13. Epizootic lymphangitis
CHAPTER 3.4.14. Japanese encephalitis
SECTION 3.5. PIG DISEASES
CHAPTER 3.5.1. Atrophic rhinitis of pigs
CHAPTER 3.5.2. Porcine brucellosis
CHAPTER 3.5.3. Trichinellosis
CHAPTER 3.5.4. Enterovirus encephalomyelitis
CHAPTER 3.5.5. Transmissible gastroenteritis
SECTION 3.6. BIRD DISEASES
CHAPTER 3.6.1. Infectious bursal disease
CHAPTER 3.6.2. Marek's disease
CHAPTER 3.6.3. Mycoplasmosis
CHAPTER 3.6.4. Psittacosis/ornithosis
CHAPTER 3.6.5. Pullorum-typhoid disease
CHAPTER 3.6.6. Avian infectious bronchitis
CHAPTER 3.6.7. Avian infectious laryngotracheitis
CHAPTER 3.6.8. Avian tuberculosis
CHAPTER 3.6.9. Duck virus hepatitis
CHAPTER 3.6.10. Duck virus enteritis
CHAPTER 3.6.11. Fowl cholera
CHAPTER 3.6.12. Salmonella enteritidis and Salmonella typhimurium in poultry
SECTION 3.7. LAGOMORPH DISEASES
CHAPTER 3.7.1. Myxomatosis
CHAPTER 3.7.2. Tularaemia
CHAPTER 3.7.3. Viral haemorrhagic disease of rabbits
SECTION 3.8. BEE DISEASES
CHAPTER 3.8.1. Acariasis of bees
CHAPTER 3.8.2. American foulbrood
CHAPTER 3.8.3. European foulbrood
CHAPTER 3.8.4. Nosemosis of bees
CHAPTER 3.8.5. Varroasis
_________________________________________________________________

PART 4
_________________________________________________________________

APPENDICES

SECTION 4.1. DIAGNOSTIC TESTS FOR THE PURPOSE OF INTERNATIONAL TRADE
4.1.1.
APPENDIX 4.1.1.1. Diagnostic tests for the purpose of international trade
SECTION 4.2. HEALTH CONTROLS AND HYGIENE - GENERAL REQUIREMENTS
4.2.1. AI CENTRES: ACCREDITATION FOR EXPORT
APPENDIX 4.2.1.1. Bovine semen
APPENDIX 4.2.1.2. Hygienic collection and handling of fresh and preserved bovine semen
4.2.2. AI CENTRES: ACCREDITATION FOR EXPORT
APPENDIX 4.2.2.1. Porcine semen
APPENDIX 4.2.2.2. Small ruminant semen
4.2.3. COLLECTION AND PROCESSING
APPENDIX 4.2.3.1. Bovine embryos/ova
APPENDIX 4.2.3.2. Porcine embryos/ova
APPENDIX 4.2.3.3. Ovine/caprine embryos/ova
APPENDIX 4.2.3.4. In vitro fertilised bovine embryos
APPENDIX 4.2.3.5. Micromanipulated bovine embryos
APPENDIX 4.2.3.6. Laboratory rodent and rabbit embryos/ova
APPENDIX 4.2.3.7. Equine embryos/ova
4.2.4. POULTRY BREEDING FLOCKS AND HATCHERIES
APPENDIX 4.2.4.1. Hygiene and disease security procedures
4.2.5. APIARIES
APPENDIX 4.2.5.1. Sanitary control
4.2.6. BLOOD SAMPLING AND VACCINATION
APPENDIX 4.2.6.1. Hygienic precautions
SECTION 4.3. DESTRUCTION OF PATHOGENS AND INSECT VECTORS
4.3.1. DISINFECTION AND DISINSECTISATION
APPENDIX 4.3.1.1. General recommendations
4.3.2. FMD VIRUS: DESTRUCTION PROCEDURES
APPENDIX 4.3.2.1. Meat
APPENDIX 4.3.2.2. Animal products for industrial use
APPENDIX 4.3.2.3. Milk and cream
APPENDIX 4.3.2.4. Skins and trophies from wild animals susceptible to FMD
4.3.3. TSE AGENTS: INACTIVATION PROCEDURES
APPENDIX 4.3.3.1. Meat-and-bone meal
SECTION 4.4. TRANSPORT OF ANIMALS
4.4.1. PROTECTION OF ANIMALS DURING INTERNATIONAL TRANSPORT:
GENERAL RECOMMENDATIONS
APPENDIX 4.4.1.1. General principles to be observed common to all forms of transport
APPENDIX 4.4.1.2. Special considerations according to methods of transport
4.4.2. AIR TRANSPORT
APPENDIX 4.4.2.1. Selected mammalian species
_________________________________________________________________

PART 6
_________________________________________________________________

LIST OF DISEASES NOTIFIABLE TO THE OIE

SECTION 6.1. LIST A DISEASES
SECTION 6.2. LIST B DISEASES
_________________________________________________________________

_________________________________________________________________

CHAPTER 3.7.3.
VIRAL HAEMORRHAGIC DISEASE
OF RABBITS
(VHD)
_____________________


Preamble: For diagnostic tests, reference should be made to the
Manual.
Article 3.7.3.1.

For the purposes of this Code, the infective period for viral haemorrhagic disease (VHD) is 60 days.

Article 3.7.3.2.

For the purposes of this Code:

VHD free country

A country may be considered free from VHD when it has been shown that the disease has not been present for at least one year, no vaccination has been carried out in the previous 12 months, and virological or serological surveys in both domestic and wild rabbits have confirmed the absence of the disease. This period may be reduced to six months after the last case has been eliminated and disinfection procedures completed in countries adopting a stamping-out policy, and where the serological survey confirmed that the disease had not occurred in the wild rabbits.

Article 3.7.3.1.

For the purposes of this Code, the infective period for viral haemorrhagic disease (VHD) is 60 days.

Article 3.7.3.2.

For the purposes of this Code:

VHD free country

A country may be considered free from VHD when it has been shown that the disease has not been present for at least one year, no vaccination has been carried out in the previous 12 months, and virological or serological surveys in both domestic and wild rabbits have confirmed the absence of the disease. This period may be reduced to six months after the last case has been eliminated and disinfection procedures completed in countries adopting a stamping-out policy, and where the serological survey confirmed that the disease had not occurred in the wild rabbits.

VHD free establishment

An establishment may be considered to be free from VHD when it has been shown, by serological testing, that the disease has not been present for at least one year and no vaccination has been carried out in the previous 12 months. Such establishments should be regularly inspected by the Veterinary Authority.

A previously infected establishment may be considered free when six months have elapsed after the last case has been eliminated, and after:

1) a stamping-out policy has been adopted and carcasses have been disposed of by burning;

2) the rabbitry has been thoroughly disinfected and kept empty for at least six weeks;

3) the rabbitry is properly fenced to prevent the straying of wild lagomorphs into the rabbitry.

Article 3.7.3.3.

Veterinary Administrations of VHD free countries may prohibit importation or transit through their territory, directly or indirectly, from countries considered infected with VHD of live rabbits, semen, meat and non treated pelts.

Article 3.7.3.4.

When importing from VHD free countries, Veterinary Administrations of importing countries should require:

for domestic rabbits destined for breeding

the presentation of an international animal health certificate attesting that the animals:

1) showed no clinical sign of VHD on the day of shipment;

2) were kept in a VHD free country for at least the past 60 days or since birth;

for day-old rabbits destined for breeding

the presentation of an international animal health certificate attesting that the animals:

1) showed no clinical sign of VHD on the day of shipment;

2) are born from female rabbits which had been kept in a country free from VHD for at least the past 60 days.

Article 3.7.3.5.

When importing from countries considered infected with VHD, Veterinary Administrations of importing countries should require:

for domestic rabbits destined for breeding or pharmaceutical or industrial use

the presentation of an international animal health certificate attesting that the animals:

1) showed no clinical sign of VHD on the day of shipment;

AND

2) were kept in a VHD free establishment where no clinical case of VHD was found when inspected by an Official Veterinarian immediately prior to shipment;

OR

3) were kept in an establishment where no case of VHD was reported during the 60 days prior to shipment and no clinical case of VHD was found when inspected by an Official Veterinarian immediately prior to shipment; and

5) were kept in an establishment where a survey of breeding rabbits (at least 10% of the animals) were subjected to the serological test for VHD with negative results during the 60 days prior to shipment; and

6) have not been vaccinated against VHD; or

7) were vaccinated against VHD immediately before shipment (the nature of the vaccine used and the date of vaccination shall also be stated in the certificate);

for day-old rabbits destined for breeding

the presentation of an international animal health certificate attesting that the animals:

1) were kept in a VHD free establishment where no clinical case of VHD was found when inspected by an Official Veterinarian immediately prior to shipment;

OR

2) were kept in an establishment where no case of VHD was reported during the 30 days prior to shipment and no clinical sign of VHD was found when inspected by an Official Veterinarian immediately before shipment; and

3) have not been vaccinated against VHD; and

4) are born from female rabbits which were subjected to the serological test with negative results during the 60 days prior to shipment;

for domestic rabbits destined for immediate slaughter

the presentation of an international animal health certificate attesting that the animals:

1) showed no clinical sign of VHD on the day of shipment;

2) were kept in an establishment where no case of VHD was reported during the 60 days prior to shipment;

for semen

the presentation of an international animal health certificate attesting that the donor animals:

1) showed no clinical sign of VHD on the day of collection;

2) were subjected to the serological test for VHD with negative results during the 30 days prior to collection.

Article 3.7.3.6.

When importing from countries considered infected with VHD, Veterinary Administrations of importing countries should require:

for domestic rabbit meat

the presentation of an international sanitary certificate attesting that the meat originates from animals which:

1) were kept in establishments where no case of VHD was reported during the 60 days prior to transport to the abattoir;

2) were found healthy before slaughter;

3) showed no lesion of VHD at post-mortem inspection.

Article 3.7.3.7.

When importing from VHD free countries, Veterinary Administrations of importing countries should require:

for non treated pelts

the presentation of an international animal health certificate attesting that the pelts come from rabbits which had been kept in a country free from VHD for at least 60 days before slaughter.

Article 3.7.3.8.

When importing from countries considered infected with VHD, Veterinary Administrations of importing countries should require:

for pelts

the presentation of an international animal health certificate attesting that the pelts were subjected to a drying treatment for at least one month and a formalin-based treatment by spraying at a 3% concentration, or by fumigation carried out in accordance with one of the methods described in Appendix 4.2.4.1., not more than seven days prior to shipment.

TO READ MORE (INCLUDING ABOUT HOW VACCINES ARE MADE) - CLICK HERE
Click here to return to front page